Fingerprint
Dive into the research topics of 'Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics
Liwei Li, Jing Li, May Khanna, Inha Jo, Jason P. Baird, Samy O. Meroueh
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations